Quarter 2 in Review – The Highlights
The second quarter of 2015 hosted a raft of activity from the pharma and cold chain industries. This was seen in the form of mergers, landmark agreements, product launches as well as a nationwide counterfeit medicine alert. Read on for this quarter’s highlights from Pharma IQ.
- In regards to the cold chain world, research from the IMARC Group forecasted that the size of the cold chain logistics services market will expand to nearly US$13.4 billion in the next five years.
- Cryoport, Inc was chosen by Lynden International as its preferred provider to support cold chain clinical trial logistics for underrepresented diseases in Africa.
- Also, designer of high performance passive storage and transport containers for temperature sensitive biologics and pharmaceuticals, Savsu Technologies, debuted its evo smart shipping container.